Quilter PLC Novartis Ag Transaction History

Quilter PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$92.27 - $101.54 $50,748 - $55,847	-550 Reduced 62.5%	330 $33,000
Q2 2023 Jul 19, 2023	SELL	$92.52 - $104.91 $1,387 - $1,573	-15 Reduced 1.68%	880 $88,000
Q1 2023 May 16, 2023	BUY	$80.03 - $92.81 $71,626 - $83,064	895 New	895 $82,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $344,861 - $381,338	-4,327 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $8,586 - $9,989	105 Added 2.49%	4,327 $354,000
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $17,900 - $19,771	-210 Reduced 4.74%	4,222 $385,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $13,193 - $15,558	-158 Reduced 3.44%	4,432 $379,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $16,706 - $20,208	-214 Reduced 4.45%	4,590 $433,000
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $22,498 - $25,325	278 Added 6.14%	4,804 $419,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $319,852 - $448,119	4,526 New	4,526 $373,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.